Drug Name Generic Name J-Code Unclassified Drugs in excess of $10,000

Similar documents
List of Designated High-Cost Drugs

RAHF PFM ALPHANINE SD COAGULATION FACTOR IX J7193 COAGULATION FACTOR IX (RFIXFC)

Drug Name. J0129 Injection, abatacept (Orencia ), 10 mg Effective 01/01/2014. J0178 Injection, aflibercept (Eylea ), 1 mg Effective 04/01/2015

Specialty Drugs. The following is a list of medications that are considered to be specialty drugs. Specialty drugs

Aetna Better Health. Specialty Drug Program

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Specialty Drugs. The specialty drug list below is effective June 5, 2018 and is subject to change at any time.

Provider Administered Drug Program (PADP) and Physician Administered Drug VPSS List

MedStar Medicare Choice Pharmacy Services

2018 BCN Advantage Prior Authorization Criteria Last updated: November, 2017

2018 BCN Advantage Prior Authorization Criteria Last updated: April, 2018

BCBS AZ ADV PLUS * CLASSIC * PREMIER For use with members associated with the BHN Network Prior Authorization List 2015

Genetics in Cancer Therapy. Raju Kucherlapati, Ph.D. Harvard Medical School

PA Category Name Code(s) Additional Notes ABA 0364T 0365T 0366T 0367T 0373T 0374T H G0396. Applied Behavioral Analysis stage 3*

acromegaly Drugs Covered Uses Exclusion Criteria Required Medical Information Age Restriction Prescriber Restriction Coverage Duration

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Overview of Cancer. Laura Bingell RN Transition Center Nurse for MFP (607)

Percent Brand Name Generic Name Strength How Supplied NDC from AWP/SWP Adcetris. Amprya dalfampridine 10 mg 60 count bottle

Exclusion Reasons Presumption of Long- Term Non-Acute Administration C9399 Unclassified Drugs or

SELF-ADMINISTERED MEDICATIONS LIST

ACAMPROSATE (CAMPRAL)

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

ORAL ONCOLOGY CRITERIA

PA Category Name Code(s) Additional Notes ABA. Applied Behavioral Analysis stage 3*

DRUGS REQUIRING PRIOR AUTHORIZATION

OPENING KEYNOTE: PRECISION MEDICINE AT THE INFLECTION POINT. Session PM1, March 5, 2018 Damon Hostin, CEO, Precision Medicine Alliance, LLC

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

Pharmacy Services Request Types

Specialty Pipeline Update

ORAL ONCOLOGY CRITERIA

Pharmacy Medical Necessity Guidelines: Oral Cancer Medications

Specialty Pipeline Update

METABOLIC, IMMUNE DISORDERS OR INHERITED RARE DISEASE ALPHA-1 PROTEINASE INHIBITORS ARANESP BLOOD CELL DEFICIENCY ARANESP ARCALYST

INJECTABLE MEDICINES. Resources, Links or Additional Information. J Code Brand Names Generic names Prior Authorization or Restrictions

March 2017 Pharmacy & Therapeutics Committee Decisions

Lista de medicamentos especializados

LIMITED DISTRIBUTION MEDICATIONS

Specialty Pipeline Update

Specialty Pharmacy Pipeline

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

P&T/Formulary Committee Actions (1Q18)

Pharmacy Policy Bulletin

MEDICAL NECESSITY GUIDELINE

Vivida Health Specialty Pharmacy Drugs (Injectable) Prior-Authorization Requirements Effective 1/1/19

SPECIALTY PHARMACY Master Clinical Drug List

Injections Requiring Prior Authorization

CENTENE PHARMACY & THERAPEUTICS COMMITTEE SECOND QUARTER 2017 AMBETTER GUIDELINE SUMMARY. Revision Summary or Description

ANTI-PARIKSON'S AGENT- DUOPA

Formulary Changes. One mission: you TABLE A. FORMULARY CHANGES 7/1/2018: Commercial 3-Tier Formulary. Commercial 4-Tier Formulary

Buckeye Health Plan (MMP) 2016 Prior Authorization Criteria

ORAL ONCOLOGY CRITERIA LENGTH OF AUTHORIZATION: Varies; Maximum of one year

Descriptor Brand Name. Alprostadil, Caverject, Edex, Prostin VR Pediatric. Calcimar, Miacalcin

January 2018 Pharmacy & Therapeutics Committee Decisions

Pulmonary Hypertension Weight Loss Skin Conditions. Skin Conditions Multiple Sclerosis Endocrine Disorder. Endocrine Disorder.

Specialty Overview by Prior Authorization Approval or Denial 2nd Quarter 2016

Drug Class Prior Authorization Criteria Therapeutic Agents in Rheumatic and Inflammatory Diseases

2018 INJECTABLE DRUG PRIOR AUTHORIZATION CRITERIA

Specialty Drug List - Sorted by Therapeutic Class Developed for the Mississippi Division of Medicaid by Mercer

ALPHA1-PROTEINASE INHIBITOR

Essential Health Benefits Standard Specialty PA and QL List July 2016

2018 MDwise Excel Network Hoosier Healthwise Medical Services that Require Prior Authorization

Pan-Canadian Pharmaceutical Alliance: Completed Negotiations

May 2016 P & T Updates

Presbyterian Health Plan, Inc. Presbyterian Insurance Company, Inc. NOTIFICATION OF FORMULARY CHANGES

Injectable Drugs Requiring Pre-Service Approval

Pan-Canadian Pharmaceutical Alliance: Completed Negotiations

2018 MDwise Excel Network Hoosier Healthwise Medical Services that Require Prior Authorization

Specialty Pipeline Update

Prior Authorization Program

Chemotherapy 101 for Radiation Oncology Workers

Specialty Overview by Prior Authorization Approval or Denial 4th Quarter 2016

2017 MDwise HIP Medical Services that Require Prior Authorization

Pan-Canadian Pharmaceutical Alliance: Completed Negotiations

MDwise Self-Administered Codes for Medical

NICE TA Adherence Check list April Drug Indication NICE Approval Release Date

ADCIRCA. Products Affected Adcirca. Prior Authorization Criteria 2017 MMP Effective Date: 11/01/2017 Approval Date: 11/01/2017

Opening Address: A Quick Survey Thinking 25 Years Backwards & Forwards

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Presbyterian Health Plan, Inc. Presbyterian Insurance Company, Inc. NOTIFICATION OF FORMULARY CHANGES

NICE TA Adherence Check List

Pan-Canadian Pharmaceutical Alliance: Completed Negotiations

Date of Guidance Title of Guidance Summary of Recommendations Ratified at Croydon Time to Publication Number Prescribing Committee Implementation

Pan-Canadian Pharmaceutical Alliance: Completed Negotiations

Pan-Canadian Pharmaceutical Alliance: Completed Negotiations

Drug Name Description of Change Formulary Coverage Formulary Alternative(s)

Cimzia. Cimzia (certolizumab pegol) Description

PHARMACY AND THERAPEUTICS COMMITTEE 4 th Quarter 2017

Formulary Chemotherapy Agents: (Current as of 6/2018) Therapeutic Class

2019 INJECTABLE DRUG PRIOR AUTHORIZATION CRITERIA

BCN Advantage SM requirements for drugs covered under the medical benefit

Protocol Number Tumour Group Protocol Name on NCCP website 22/02/ Lung Afatinib Monotherapy 244 Gastrointestinal Regorafenib Monotherapy

INJECTION, INOTUZUMAB OZOGAMICIN, 0.1 MG [BESPONSA ] [C CODES FOR FACILITY USE ONLY]

Ally Rx D-SNP Current as of r 1, 2017

Prior Authorization Program Information (Effective April 1st, 2018)

Protocol Number Intrathecal Methotrexate for CNS 01/02/2018 Prophylaxis in GTN Gynaecology 249

SUPPLEMENTARY INFORMATION

Immune Modulating Drugs Prior Authorization Request Form

Cosentyx. Cosentyx (secukinumab) Description

Transcription:

Unclassified Drugs in excess of $10,000 J3490 Unclassified Biologics in excess of $10,000 J3590 Revenue Codes in excess of $10,000 R250 - R259 ABRAXANE paclitaxel protein-bound J9264 & J9267 ACTEMRA tocilizumab J3262 ACTHAR repository corticotropin J0800 ACTIMMUNE interferon gamma-1b J9216 ADAGEN pegademase bovine J2504 ADCETRIS brentuximab vedotin J9042 ADCIRCA tadalafil oral ADEMPAS riociguat oral ADVATE (All Forms) antihemophilic factor, recombinant J7186 AFINITOR everolimus oral J7527 AFINITOR DISPERZ everolimus oral soluble J7527 ALECENSA alectinib oral ALPHANINE SD factor IX (human) J7193, J7194, J7200, J7201, 77202 AMPYRA dalfampridine (4-aminopyridine) oral APOKYN apomorphine hydrochloride J0364 ARCALYST rilonacept J2793 ATRIPLA efavirenz/emtricitabine/tenofovir disoproxil fumarate oral AUBAGIO teriflunomide oral AVASTIN bevacizumab J9035 AVONEX interferon beta-1a J1826 & Q3027 AVONEX PEN KIT interferon beta-1a J1826 & Q3027 BENEFIX factor IX (recombinant) J7195 BENLYSTA belimumab J0490 BERINERT C1 inhibitor, human BETASERON interferon beta-1b J1830 BETHKIS tobramycin oral inhalation J7682 & J7685 BICNU carmustine (BCNU) J9050 BLINCYTO blinatumomab J9039 BOSULIF bosutinib oral BRAVELLE urofollitropin J3355 Page 1 of 7 7/5/2017

CAPRELSA vandetanib oral CARIMUNE NF intravenous CAYSTON aztreonam inhalation CEREZYME imiglucerase CETROTIDE cetrorelix acetate CIMZIA certolizumab pegol CIMZIA PREFL KIT certolizumab pegol J0717 & J0718 CINQAIR reslizumab CINRYZE C1 inhibitor, human COMETRIQ cabozantinib malate oral COMPLERA emtricitabine/rilpivirine hydrochloride/tenofovir disoproxil fumarate oral COPAXONE* glatiramer acetate J1595 Corlanor ivabradine oral COSENTYX secukinumab COSENTYX PEN INJ secukinumab COTELLIC cobimetinib fumarate oral DAKLINZA daclatasvir dihydrochloride oral ELAPRASE idursulfase J1743 ELOCTATE antihemophilic factor, recombinant (Fc Fusion Protein) J7186 ENBREL SRCLK* etanercept J1438 ENBREL* etanercept J1438 Enstilar calcipotriene/betamethasone dipropionate topical ENTYVIO* vedolizumab J3380 EPCLUSA sofosbuvir/velpatasvir oral EPOGEN epoetin alfa recombinant (erythropoietin; EPO) J0885 & J0886 ERIVEDGE vismodegib oral ESBRIET pirfenidone oral Evzio naloxone hydrochloride J2310 EXJADE deferasirox oral EXTAVIA interferon beta-1b J1830 EYLEA aflibercept ophthalmic J0178 FABRAZYME agalsidase beta J0180 Page 2 of 7 7/5/2017

FARYDAK panobinostat lactate oral Femara (brand only) Brand Only - generic is letrozole oral FIRAZYR icatibant acetate J1744 FORTEO teriparatide J3110 FUZEON enfuvirtide J1324 GAMMAGARD GAMMAGARD SD GAMUNEX GAMUNEX C GAZYVA obinutuzumab J9301 GENVOYA elvitegravir/cobicistat/emtricitabine/tenofo vir alafenamide fumarate oral GILENYA fingolimod hydrochloride oral GLATOPA glatiramer acetate J1595 & J7199 GLEEVEC imatinib mesylate oral S0088 HARVONI ledipasvir/sofosbuvir oral HELIXATE FS antihemophilic factor, recombinant J7186 HERCEPTIN trastuzumab J9355 HIZENTRA* subcutaneous HUMATE-P antihemophilic factor/von willebrand factor complex (factor VIII/VWF; AHF/VWF) J7186 HUMATROPE somatropin J2941 HUMIRA adalimumab J0135 HUMIRA PEN adalimumab J0135 HYCAMTIN topotecan hydrochloride /oral J8705 & J9351 HYQVIA /hyaluronidase subcutaneous & J3470 IBRANCE palbociclib oral ILARIS canakinumab J0638 ILUVIEN fluocinolone acetonide ophthalmic J7313 Page 3 of 7 7/5/2017

Imatinib (generic Gleevec) imatinib mesylate oral S0088 IMBRUVICA ibrutinib oral IMLYGIC talimogene laherparepvec J9325 INCIVEK telaprevir oral INLYTA axitinib oral INTELENCE etravirine oral ISENTRESS raltegravir potassium oral Jadenu deferasirox oral JAKAFI ruxolitinib phosphate oral KADCYLA ado-trastuzumab emtansine J9354 KALETRA lopinavir/ritonavir oral KALYDECO ivacaftor oral KYPROLIS carfilzomib J9047 LEMTRADA alemtuzumab J0202 & J9010 LETAIRIS ambrisentan oral LONSURF trifluridine/tipiracil hydrochloride oral LUCENTIS ranibizumab intravitreal J2778 LYNPARZA olaparib oral MAKENA hydroxyprogesterone caproate J1725 MATULANE procarbazine hydrochloride (N- Methylhydrazine; MIH) oral S0182 MEKINIST trametinib dimethyl sulfoxide oral NEORAL cyclosporine (cyclosporin A) oral J7502 & J7515 NEULASTA pegfilgrastim J2505 NEUPOGEN filgrastim (granulocyte colony-stimulating J1440, J1441, J1442, factor; G-CSF) J1446, J1447 NEXAVAR sorafenib tosylate oral NINLARO ixazomib oral NORDITROPIN (ALL FORMS)* somatropin J2941 NORTHERA droxidopa oral NPLATE romiplostim J2796 NUCALA mepolizumab J2182 NUTROPIN (ALL FORMS)* somatropin J2941 Nutropin Nuspin AQ* somatropin J2941 OCALIVA obeticholic acid oral OCREVUS ocrelizumab Page 4 of 7 7/5/2017

ODEFSEY emtricitabine/rilpivirine hydrochloride/tenofovir alafenamide fumarate oral ODOMZO sonidegib oral OFEV nintedanib ethanesulfonate oral OLYSIO simeprevir sodium oral OPDIVO nivolumab J9299 OPSUMIT macitentan oral ORENCIA abatacept J0129 ORENCIA-C abatacept J0129 ORENITRAM treprostinil diolamine oral J3285 & J7686 ORKAMBI lumacaftor/ivacaftor oral OTEZLA apremilast oral PEG-INTRON peginterferon alfa-2b S0148 PERJETA pertuzumab J9306 Pertzye digestive enzymes oral PLEGRIDY peginterferon beta-1a POMALYST pomalidomide oral PREZCOBIX darunavir/cobicistat oral PREZISTA darunavir ethanolate oral PRIVIGEN intravenous PROLIA denosumab J0897 PROMACTA eltrombopag olamine oral PULMOZYME dornase alfa (recombinant human deoxyribonuclease; rhdnase) inhalation J7639 RAVICTI glycerol phenylbutyrate oral Rayos prednisone oral J7506 & J7512 REBIF interferon beta-1a J1826 & Q3026 & Q3028 REBIF REBIDO interferon beta-1a J1826 & Q3026 & Q3028 REBIF TITRTN INJ PACK interferon beta-1a J1826 & Q3026 & Q3028 RELISTOR methylnaltrexone bromide oral J2212 REMICADE (Inflectra is biosimilar to Remicade) infliximab J1745 REMODULIN treprostinil sodium J3285 & J7686 REPATHA (all 3 versions) evolocumab REVATIO sildenafil citrate /oral REVLIMID lenalidomide oral REYATAZ atazanavir sulfate oral Page 5 of 7 7/5/2017

RIBAVIRIN ribavirin oral/inhalation RITUXAN rituximab J9310 SABRIL vigabatrin oral SANDIMMUNE cyclosporine (cyclosporin A) oral/ J7502 & J7515 SANDOSTATIN octreotide acetate J2353 & J2354 SENSIPAR cinacalcet hydrochloride oral SIMPONI golimumab J1602 SOMAVERT pegvisomant SOVALDI sofosbuvir oral SPINRAZA nusinersen SPRYCEL dasatinib oral STELARA ustekinumab J3357 STIVARGA regorafenib oral STRIBILD elvitegravir/cobicistat/emtricitabine/tenofo vir disoproxil fumarate oral SUCRAID sacrosidase oral SUPPRELIN LA* histrelin acetate subcutaneous SUTENT sunitinib malate oral Syprine trientine hydrochloride oral TAFINLAR dabrafenib mesylate oral TALTZ ixekizumab TARCEVA erlotinib hydrochloride oral TASIGNA nilotinib hydrochloride oral TECENTRIQ atezolizumab 9999, J3590, J3490, C948 TECFIDERA* dimethyl fumarate oral THALOMID thalidomide oral THYROGEN thyrotropin alfa J3240 TIVICAY dolutegravir sodium oral TOBI tobramycin oral inhalation J7682 TOBI PODHALR tobramycin oral inhalation J7682 Tobramycin inhaled (generic Tobi) tobramycin oral inhalation J7682 Topotecan (generic Hycamtin) topotecan hydrochloride /oral J8705 & J9351 TRIUMEQ abacavir sulfate/dolutegravir sodium/lamivudine oral TYKERB lapatinib ditosylate oral TYSABRI natalizumab J2323 Page 6 of 7 7/5/2017

TYVASO treprostinil inhalation J3285 & J7686 VECTIBIX panitumumab J9303 VELCADE bortezomib J9041 VENCLEXTA venetoclax oral Viberzi eluxadoline oral VIEKIRA ombitasvir/paritaprevir/ritonavir/dasabuvir sodium oral VIREAD tenofovir disoproxil fumarate oral Vivaglobin VIVITROL naltrexone J2315 VOTRIENT pazopanib hydrochloride oral VPRIV velaglucerase alfa J3385 VRAYLAR cariprazine oral XALKORI crizotinib oral XELJANZ tofacitinib citrate oral XENAZINE tetrabenazine oral XGEVA denosumab J0897 XIAFLEX collagenase clostridium histolyticum J0775 Xifaxan* rifaximin oral XOLAIR omalizumab J2357 XTANDI enzalutamide oral XYREM sodium oxybate oral ZELBORAF vemurafenib oral ZEMAIRA alpha 1-proteinase inhibitor, human (alpha 1-antitrypsin) J0256 ZEPATIER elbasvir/grazoprevir oral ZOLADEX goserelin acetate implant J9202 ZORTRESS everolimus oral J7527 ZYDELIG idelalisib oral ZYKADIA ceritinib oral ZYTIGA abiraterone acetate oral Page 7 of 7 7/5/2017